Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.52% | -25.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.52% | -25.00% | |||
| Cost of Revenue | 43.95% | -16.04% | |||
| Gross Profit | -56.52% | 12.21% | |||
| SG&A Expenses | 12.44% | -7.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.86% | -9.22% | |||
| Operating Income | -12.89% | 9.05% | |||
| Income Before Tax | -8.23% | 22.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.23% | 22.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.23% | 22.52% | |||
| EBIT | -12.89% | 9.05% | |||
| EBITDA | -12.73% | 9.12% | |||
| EPS Basic | 37.81% | -25.65% | |||
| Normalized Basic EPS | 17.04% | 7.00% | |||
| EPS Diluted | 38.56% | -27.18% | |||
| Normalized Diluted EPS | 17.04% | 7.00% | |||
| Average Basic Shares Outstanding | 30.48% | -16.68% | |||
| Average Diluted Shares Outstanding | 30.48% | -16.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.83% | 0.57% | |||